Intellia Therapeutics Inc buy Cantor Fitzgerald
Start price
13.09.23
/
50%
€34.13
Target price
13.09.24
€60.55
Performance (%)
-41.20%
End price
14.09.24
€20.07
Summary
This prediction ended on 14.09.24 with a price of €20.07. Massive losses of -41.20% were the result for the BUY prediction by Cantor_Fitzgerald. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.634% | -3.634% | -1.932% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€23.43
24.06.24
24.06.24
€60.53
24.06.25
24.06.25
-64.98%
25.06.25
25.06.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.97
18.06.24
18.06.24
€60.53
18.06.25
18.06.25
-64.30%
19.06.25
19.06.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€21.64
04.06.24
04.06.24
€59.71
04.06.25
04.06.25
-68.59%
05.06.25
05.06.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.09
29.08.23
29.08.23
€59.70
29.08.24
29.08.24
-42.43%
30.08.24
30.08.24
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€37.03
10.08.23
10.08.23
€58.92
10.08.24
10.08.24
-46.44%
11.08.24
11.08.24